Charles Weston
Stock Analyst at RBC Capital
(0.15)
# 4,542
Out of 4,649 analysts
350
Total ratings
37.8%
Success rate
-6.6%
Average return
Main Sectors:
Stocks Rated by Charles Weston
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ETR: EVT Evotec SE | Maintained: Buy | €10.00 | €3.45 | +190.19% | 54 | Aug 13, 2026 | |
| ETR: SRT3 Sartorius Aktiengesellschaft | Maintained: Hold | €220.00 | €237.50 | -7.37% | 23 | Aug 12, 2026 | |
| EPA: DIM Sartorius Stedim Biotech S.A. | Maintained: Buy | €210.00 | €185.50 | +13.21% | 22 | Aug 12, 2026 | |
| BIT: 1SXP SCHOTT Pharma AG & Co. KGaA | Maintained: Buy | €21.00 | €21.85 | -3.89% | 9 | Aug 12, 2026 | |
| LON: OXB Oxford Biomedica plc | Reiterated: Buy | 1,140p → 900p | 487p | +84.80% | 30 | Aug 10, 2026 | |
| ETR: AFX Carl Zeiss Meditec AG | Maintained: Hold | €32.00 | €32.28 | -0.87% | 2 | Aug 6, 2026 | |
| LON: SN Smith & Nephew plc | Maintained: Hold | 1,350p → 1,250p | 1,096p | +14.05% | 2 | Aug 6, 2026 | |
| SWX: LONN Lonza Group AG | Maintained: Buy | CHF 760.00 | CHF 562.60 | +35.09% | 40 | Aug 3, 2026 | |
| LON: CTEC Convatec Group PLC | Maintained: Buy | 215p → 315p | 230p | +37.20% | 15 | Aug 2, 2026 | |
| SWX: BANB Bachem Holding AG | Maintained: Buy | CHF 110.00 | CHF 75.25 | +46.18% | 12 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | CHF 44.00 | CHF 44.10 | -0.23% | 9 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 1,600p → 1,400p | 550p | +154.55% | 4 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 225p | 122p | +84.43% | 31 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 108.00 → CHF 96.00 | CHF 78.75 | +21.90% | 16 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 1,900p | 1,307p | +45.37% | 23 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 480p → 411p | 365p | +12.65% | 21 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $69.18 | - | 1 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $289 | $111.59 | n/a | 1 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 310p | 234p | n/a | 20 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | CHF 26.00 | CHF 3.37 | n/a | 4 | Jul 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | kr 287.00 | kr 39.16 | n/a | 2 | Apr 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 160p | 69p | n/a | 1 | Nov 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7.05 | $0.808 | n/a | 8 | Apr 24, 2018 |
Evotec SE
Aug 13, 2026
Maintained: Buy
Price Target: €10.00
Current: €3.45
Upside: +190.19%
Sartorius Aktiengesellschaft
Aug 12, 2026
Maintained: Hold
Price Target: €220.00
Current: €237.50
Upside: -7.37%
Sartorius Stedim Biotech S.A.
Aug 12, 2026
Maintained: Buy
Price Target: €210.00
Current: €185.50
Upside: +13.21%
SCHOTT Pharma AG & Co. KGaA
Aug 12, 2026
Maintained: Buy
Price Target: €21.00
Current: €21.85
Upside: -3.89%
Oxford Biomedica plc
Aug 10, 2026
Reiterated: Buy
Price Target: 1,140p → 900p
Current: 487p
Upside: +84.80%
Carl Zeiss Meditec AG
Aug 6, 2026
Maintained: Hold
Price Target: €32.00
Current: €32.28
Upside: -0.87%
Smith & Nephew plc
Aug 6, 2026
Maintained: Hold
Price Target: 1,350p → 1,250p
Current: 1,096p
Upside: +14.05%
Lonza Group AG
Aug 3, 2026
Maintained: Buy
Price Target: CHF 760.00
Current: CHF 562.60
Upside: +35.09%
Convatec Group PLC
Aug 2, 2026
Maintained: Buy
Price Target: 215p → 315p
Current: 230p
Upside: +37.20%
Bachem Holding AG
Jul 31, 2026
Maintained: Buy
Price Target: CHF 110.00
Current: CHF 75.25
Upside: +46.18%
Jul 7, 2026
Downgraded: Hold
Price Target: CHF 44.00
Current: CHF 44.10
Upside: -0.23%
Jun 15, 2026
Maintained: Buy
Price Target: 1,600p → 1,400p
Current: 550p
Upside: +154.55%
May 26, 2026
Reiterated: Buy
Price Target: 225p
Current: 122p
Upside: +84.43%
Mar 16, 2026
Maintained: Hold
Price Target: CHF 108.00 → CHF 96.00
Current: CHF 78.75
Upside: +21.90%
Mar 4, 2026
Maintained: Buy
Price Target: 1,900p
Current: 1,307p
Upside: +45.37%
Feb 24, 2026
Maintained: Buy
Price Target: 480p → 411p
Current: 365p
Upside: +12.65%
Feb 11, 2026
Upgraded: Buy
Price Target: n/a
Current: $69.18
Upside: -
Jan 7, 2025
Reiterated: Buy
Price Target: $289
Current: $111.59
Upside: n/a
Nov 19, 2024
Maintained: Buy
Price Target: 310p
Current: 234p
Upside: n/a
Jul 12, 2021
Maintained: Buy
Price Target: CHF 26.00
Current: CHF 3.37
Upside: n/a
Apr 13, 2021
Maintained: Buy
Price Target: kr 287.00
Current: kr 39.16
Upside: n/a
Nov 2, 2018
Maintained: Buy
Price Target: 160p
Current: 69p
Upside: n/a
Apr 24, 2018
Maintained: Buy
Price Target: $7.05
Current: $0.808
Upside: n/a